| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
K.HVVFGK.I 2.12 2.01 343.7052 34.05 - 41.98 2 5E5 35.77 168 173 N
Q.TPWLDGK.H 2.53 1.07 408.7180 59.48 - 66.56 2 3.5E5 61.88 161 167 N
K.TAENFIALATGEK.G Y 2.62 4.58 682.8586 105.71 - 110.14 2 2.4E5 107.71 72 84 Y
K.DFMIQGGDFTR.G Y 2.14 2.20 643.7977 93.82 - 97.62 2 1.5E5 95.45 99 109 Y
K.GFGYK.G 0.28 6.33 571.2968 36.53 - 40.45 1 1.3E5 37.70 85 89 N
K.VFFDMK.V Y 2.14 8.21 393.6980 84.33 - 89.40 2 1.2E5 86.55 46 51 Y
R.IVIGVFGK.T Y 0.53 7.62 416.7747 93.11 - 96.05 2 1.2E5 94.43 60 67 N
K.GFGYK.G 0.52 2.89 571.2851 36.77 - 44.84 1 1.1E5 39.02 85 89 N
R.IVIGVFGK.T Y 0.73 3.92 416.7673 93.36 - 97.35 2 1.1E5 95.48 60 67 N
K.ILEGMDVVK.K Y 0.34 7.22 502.2887 75.39 - 80.50 2 1E5 77.75 174 182 N
K.ILEGMDVVK.K Y 0.83 3.40 502.2790 73.39 - 80.36 2 1E5 76.51 174 182 N
K.SIYGDRFPDENFK.L Y 2.09 7.39 529.9226 75.46 - 81.46 3 9.9E4 78.50 119 131 N
K.VGDEEVGR.I Y 1.61 2.12 430.7144 29.41 - 34.38 2 8.9E4 30.69 52 59 N
F.ITTIQTPWLDGK.H Y 2.17 1.98 686.8799 102.47 - 106.50 2 7.4E4 104.50 156 167 N
K.IDVDQPFAVPK.E Y 0.43 2.95 614.8287 89.84 - 93.18 2 7.1E4 91.39 207 217 N
K.H(+43.01)VVFGK.I 1.20 2.11 365.2110 46.44 - 54.75 2 6.7E4 48.56 168 173 N Carbamylation
K.IDVDQPFAVPK.E Y 0.38 7.31 614.8418 89.63 - 92.14 2 6.6E4 90.81 207 217 N
K.HYAPGWLSMANAGK.D Y 0.66 5.70 501.5849 83.68 - 89.21 3 5.2E4 86.19 134 147 N
K.HVVFGK.I 1.56 4.63 686.4015 34.08 - 41.41 1 4.7E4 35.77 168 173 N
K.HYAPGWLSMANAGK.D Y 0.79 3.18 751.8670 83.55 - 89.34 2 4E4 86.20 134 147 N
R.VIKDFMIQGGDFTR.G Y 0.90 12.68 542.9567 93.33 - 96.74 3 3.9E4 95.24 96 109 N
R.FPDENFK.L 0.33 7.28 448.7234 54.07 - 60.82 2 3.8E4 56.93 125 131 N
R.FPDENFK.L 0.32 6.60 448.7122 55.07 - 60.26 2 3.5E4 57.62 125 131 N
K.IDVDQPFAVPKE Y 0.33 6.50 679.3601 90.48 - 92.34 2 3E4 91.64 207 218 N
K.SIYGDRFPDENFK.L Y 1.10 4.86 794.3781 76.13 - 79.90 2 2.7E4 78.15 119 131 N
K.TAENFIALATGEK.G Y 1.84 6.97 455.5756 105.71 - 109.68 3 2.7E4 107.72 72 84 N
K.DVVIHDCGK.I Y 1.00 1.34 493.2431 36.26 - 44.80 2 2.5E4 38.44 198 206 N
Q.TPWLDGK.H 0.66 1.87 816.4208 60.41 - 66.69 1 2.2E4 62.21 161 167 N
K.G(+43.01)FGYK.G 0.30 0.90 614.2952 48.93 - 53.30 1 2.1E4 50.70 85 89 N Carbamylation
K.H(+43.01)YAPGWLSMANAGK.D Y 1.06 3.80 773.3703 101.64 - 105.36 2 2E4 103.44 134 147 N Carbamylation
Q.TPWLDGK.H 0.22 6.00 816.4379 59.33 - 62.62 1 1.9E4 60.78 161 167 N
K.HYAPGWLSMANAGK.D Y 0.08 5.46 501.5711 86.02 - 87.92 3 1.8E4 86.80 134 147 N
K.H(+43.01)VVFGK.I 0.11 5.77 365.2033 46.97 - 54.59 2 1.8E4 49.77 168 173 N Carbamylation
R.IVIGVFGK.T Y 1.46 3.15 832.5336 93.11 - 97.22 1 1.7E4 94.98 60 67 N
K.VFFDMK.V Y 0.92 3.20 786.3906 83.82 - 88.21 1 1.7E4 86.42 46 51 N
K.DTNGSQFFITTIQTPWLDGK.H Y 1.46 1.94 757.0491 133.34 - 134.14 3 1.5E4 133.79 148 167 N
R.DKPLKDVVIHDCGK.I Y 0.44 2.38 392.4657 48.58 - 53.25 4 1.4E4 51.08 193 206 N
R.DKPLKDVVIHDCGK.I Y 0.46 1.94 522.9504 48.82 - 52.35 3 1.3E4 50.82 193 206 N
Q.T(+43.01)PWLDGK.H 1.26 2.73 859.4354 86.34 - 90.57 1 1.3E4 88.29 161 167 N Carbamylation
R.VIKDFMIQGGDFTR.G Y 0.20 6.21 542.9428 92.46 - 97.93 3 1.3E4 95.90 96 109 N
R.VIKDFMIQGGDFTR.G Y 0.59 2.76 813.9197 91.46 - 97.60 2 8.2E3 95.61 96 109 N
F.FITTIQTPWLDGK.H Y 1.07 0.32 760.4136 122.52 - 125.38 2 6.6E3 124.06 155 167 N
K.ILEGMDVVKK.I Y 0.13 0.84 377.8784 58.07 - 62.68 3 4.6E3 60.16 174 183 N
K.T(+43.01)AENFIALATGEK.G Y 0.78 1.48 704.3643 131.23 - 132.19 2 4.5E3 131.56 72 84 N Carbamylation
K.TAENFIALATGEK.G Y 1.12 7.63 1364.7089 105.67 - 109.48 1 2.3E3 107.80 72 84 N
K.DTNGSQFFITTIQTPWLDGK.H Y 0.19 5.74 1135.0434 132.34 - 134.09 2 2.2E3 133.46 148 167 N
K.DTNGSQFFITTIQT(-18.01)PWLDGK.H Y 0.35 7.45 751.0510 133.74 - 134.33 3 2E3 133.95 148 167 N Phospho neutral loss (ST)
total 47 peptides